This document is an excerpt from the EUR-Lex website
Document 22026D0654
Decision of the EEA Joint Committee No 278/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/654]
Decision of the EEA Joint Committee No 278/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/654]
Decision of the EEA Joint Committee No 278/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/654]
OJ L, 2026/654, 16.4.2026, ELI: http://data.europa.eu/eli/dec/2026/654/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
Official Journal |
EN L series |
|
2026/654 |
16.4.2026 |
DECISION OF THE EEA JOINT COMMITTEE No 278/2025
of 5 December 2025
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/654]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Decision (EU) 2025/1791 of 10 September 2025 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Decision (EU) 2025/1792 of 10 September 2025 postponing the expiry date of the approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Decision (EU) 2025/1778 of 11 September 2025 postponing the expiry date of the approval of copper pyrithione for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Commission Implementing Decision (EU) 2025/1779 of 11 September 2025 postponing the expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (4) is to be incorporated into the EEA Agreement. |
|
(5) |
Commission Implementing Decision (EU) 2025/1806 of 11 September 2025 postponing the expiry date of the approval of transfluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (5) is to be incorporated into the EEA Agreement. |
|
(6) |
Commission Implementing Decision (EU) 2025/1809 of 11 September 2025 postponing the expiry date of the approval of zineb for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (6) is to be incorporated into the EEA Agreement. |
|
(7) |
Commission Implementing Decision (EU) 2025/1811 of 11 September 2025 postponing the expiry date of the approval of 4,5-Dichloro-2-octyl-2H-isothiazol-3-one for use in biocidal products of product-types 8 and 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (7) is to be incorporated into the EEA Agreement. |
|
(8) |
Commission Implementing Decision (EU) 2025/1814 of 11 September 2025 postponing the expiry date of the approval of lauric acid for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (8) is to be incorporated into the EEA Agreement. |
|
(9) |
Commission Implementing Decision (EU) 2025/1807 of 12 September 2025 postponing the expiry date of the approval of copper thiocyanate for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (9) is to be incorporated into the EEA Agreement. |
|
(10) |
Commission Implementing Decision (EU) 2025/1812 of 12 September 2025 postponing the expiry date of the approval of dicopper oxide for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (10) is to be incorporated into the EEA Agreement. |
|
(11) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzzzzzzzzzb (Commission Implementing Decision (EU) 2025/946) of Chapter XV of Annex II to the EEA Agreement:
|
‘12zzzzzzzzzzzzc. |
32025 D 1791: Commission Implementing Decision (EU) 2025/1791 of 10 September 2025 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1791, 11.9.2025). |
|
12zzzzzzzzzzzzd. |
32025 D 1792: Commission Implementing Decision (EU) 2025/1792 of 10 September 2025 postponing the expiry date of the approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1792, 11.9.2025). |
|
12zzzzzzzzzzzze. |
32025 D 1778: Commission Implementing Decision (EU) 2025/1778 of 11 September 2025 postponing the expiry date of the approval of copper pyrithione for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1778, 12.9.2025). |
|
12zzzzzzzzzzzzf. |
32025 D 1779: Commission Implementing Decision (EU) 2025/1779 of 11 September 2025 postponing the expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1779, 12.9.2025). |
|
12zzzzzzzzzzzzg. |
32025 D 1806: Commission Implementing Decision (EU) 2025/1806 of 11 September 2025 postponing the expiry date of the approval of transfluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1806, 12.9.2025). |
|
12zzzzzzzzzzzzh. |
32025 D 1809: Commission Implementing Decision (EU) 2025/1809 of 11 September 2025 postponing the expiry date of the approval of zineb for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1809, 12.9.2025). |
|
12zzzzzzzzzzzzi. |
32025 D 1811: Commission Implementing Decision (EU) 2025/1811 of 11 September 2025 postponing the expiry date of the approval of 4,5-Dichloro-2-octyl-2H-isothiazol-3-one for use in biocidal products of product-types 8 and 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1811, 12.9.2025). |
|
12zzzzzzzzzzzzj. |
32025 D 1814: Commission Implementing Decision (EU) 2025/1814 of 11 September 2025 postponing the expiry date of the approval of lauric acid for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1814, 12.9.2025). |
|
12zzzzzzzzzzzzk. |
32025 D 1807: Commission Implementing Decision (EU) 2025/1807 of 12 September 2025 postponing the expiry date of the approval of copper thiocyanate for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1807, 15.9.2025). |
|
12zzzzzzzzzzzzl. |
32025 D 1812: Commission Implementing Decision (EU) 2025/1812 of 12 September 2025 postponing the expiry date of the approval of dicopper oxide for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/1812, 15.9.2025).’ |
Article 2
The texts of Implementing Decisions (EU) 2025/1791, (EU) 2025/1792, (EU) 2025/1778, (EU) 2025/1779, (EU) 2025/1806, (EU) 2025/1809, (EU) 2025/1811, (EU) 2025/1814, (EU) 2025/1807 and (EU) 2025/1812 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 6 December 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 5 December 2025.
For the EEA Joint Committee
The President
Stefán Haukur JÓHANNESSON
(1) OJ L, 2025/1791, 11.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1791/oj.
(2) OJ L, 2025/1792, 11.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1792/oj.
(3) OJ L, 2025/1778, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1778/oj.
(4) OJ L, 2025/1779, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1779/oj.
(5) OJ L, 2025/1806, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1806/oj.
(6) OJ L, 2025/1809, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1809/oj.
(7) OJ L, 2025/1811, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1811/oj.
(8) OJ L, 2025/1814, 12.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1814/oj.
(9) OJ L, 2025/1807, 15.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1807/oj.
(10) OJ L, 2025/1812, 15.9.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1812/oj.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2026/654/oj
ISSN 1977-0677 (electronic edition)